AIM ImmunoTech (0A4Y) Financial Statements
AIM ImmunoTech Financial Overview
AIM ImmunoTech's market cap is currently $6.16M. The company's EPS TTM is $-3.84; its P/E ratio is -0.04; AIM ImmunoTech has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Dec 24 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 88.00K | $ 170.00K | $ 202.00K | $ 141.00K | $ 135.00K |
| Gross Profit | $ -250.00K | $ 139.00K | $ 160.00K | $ 141.00K | $ -715.00K |
| Operating Income | $ -10.53M | $ -19.77M | $ -31.92M | $ -19.92M | $ -18.84M |
| EBITDA | $ -12.94M | $ -16.49M | $ -28.72M | $ -19.19M | $ -18.29M |
| Net Income | $ -13.96M | $ -17.32M | $ -28.96M | $ -19.45M | $ -19.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 993.00K | $ 3.98M | $ 13.07M | $ 34.19M | $ 48.27M |
| Total Assets | $ 5.78M | $ 8.61M | $ 19.38M | $ 40.49M | $ 57.70M |
| Total Debt | $ 4.90M | $ 2.94M | $ 718.00K | $ 837.00K | $ 149.00K |
| Net Debt | $ 3.96M | $ 1.24M | $ -4.72M | $ -26.22M | $ -31.94M |
| Total Liabilities | $ 15.56M | $ 9.93M | $ 9.15M | $ 2.02M | $ 820.00K |
| Stockholders' Equity | $ -9.78M | $ -1.32M | $ 10.23M | $ 38.47M | $ 56.88M |
| Cash Flow | |||||
| Free Cash Flow | $ -11.34M | $ -14.91M | $ -21.85M | $ -16.38M | $ -14.01M |
| Operating Cash Flow | $ -10.96M | $ -14.89M | $ -21.27M | $ -16.11M | $ -13.96M |
| Investing Cash Flow | $ 1.85M | $ 4.71M | $ -832.00K | $ 10.99M | $ -631.00K |
| Financing Cash Flow | $ 10.39M | $ 6.44M | $ 485.00K | $ 80.00K | $ 8.19M |
Currency in USD
